Companies: 10,795·Total market cap: $144.5T
Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTXNASDAQHealthcare● Active
$7.55
+$0.08(+1.07%)
Market Cap$330627403
P/E Ratio
52W High$13.67
52W Low$2.52

Kyverna Therapeutics, Inc. (KYTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · KYTX · as of Mar 26, 2026

Latest filing snapshot

130
+18+16.07%vs prior year

Kyverna Therapeutics, Inc. (KYTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
130
Change (1Y)
+18
Growth % (1Y)
+16.07%
Revenue / Employee
Net Income / Employee
$-1.24M
Market Cap
$331M

KYTX Employee Count

2023 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-26130+18+16.07%
2025-03-27112+16+16.67%
2024-03-2696

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Editas Medicine, Inc.
EDIT
Editas Medicine, Inc.
246
#2
Allogene Therapeutics, Inc.
ALLO
Allogene Therapeutics, Inc.
226
#3
Cabaletta Bio, Inc.
CABA
Cabaletta Bio, Inc.
161
#4
Capricor Therapeutics, Inc.
CAPR
Capricor Therapeutics, Inc.
160
#5
Kyverna Therapeutics, Inc.
KYTX
Kyverna Therapeutics, Inc.YOU
130
#6
Atea Pharmaceuticals, Inc.
AVIR
Atea Pharmaceuticals, Inc.
56
#7
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
41
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · KYTX peer comparison

About KYTX employees

KYTX Employees · Headcount

Kyverna Therapeutics, Inc. (KYTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Kyverna Therapeutics, Inc. had 130 full-time employees globally. Full-time employees only. Global consolidated headcount.

Kyverna Therapeutics, Inc.'s workforce increased by 18 (16.07%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

KYTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Kyverna Therapeutics, Inc. had 130 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Kyverna Therapeutics, Inc. employee counthow many employees does Kyverna Therapeutics, Inc. haveKYTX total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-26